VBI VACCINES INC (VBIV) Stock Analyst Ratings
USA - NASDAQ:VBIV - CA91822J2020 - Common Stock
0.0653 USD
-0.07 (-50.87%)
0.045 USD
-0.02 (-31.09%)
ChartMill assigns a Buy % Consensus number of 83% to VBIV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 7710.11% above the current price.
VBIV was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VBIV.
In the previous month the buy percentage consensus was at a similar level.
VBIV was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-13 | Raymond James | Maintains | Outperform |
| 2022-11-11 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2022-08-09 | Raymond James | Maintains | Strong Buy |
| 2022-03-08 | Raymond James | Maintains | Strong Buy |
VBI VACCINES INC / VBIV FAQ
What do analysts expect the price target to be for VBI VACCINES INC (VBIV)?
7 analysts have analysed VBIV and the average price target is 5.1 USD. This implies a price increase of 7710.11% is expected in the next year compared to the current price of 0.0653.
What is the consensus rating for VBIV stock?
The consensus rating for VBI VACCINES INC (VBIV) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.